Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $6.72 and traded as low as $6.40. Coloplast A/S shares last traded at $6.45, with a volume of 112,052 shares trading hands.
Coloplast A/S Stock Down 0.9%
The company has a market capitalization of $14.54 billion, a P/E ratio of 33.95, a PEG ratio of 2.44 and a beta of 0.16. The company has a debt-to-equity ratio of 1.51, a current ratio of 1.56 and a quick ratio of 1.09. The company has a 50 day moving average of $6.72 and a 200-day moving average of $6.52.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last released its quarterly earnings data on Tuesday, August 18th. The company reported $0.10 earnings per share for the quarter, hitting the consensus estimate of $0.10. Coloplast A/S had a return on equity of 39.27% and a net margin of 9.68%.The business had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.11 billion. As a group, equities analysts anticipate that Coloplast A/S Sponsored ADR will post 0.4 EPS for the current year.
Coloplast A/S Company Profile
Coloplast A/S is a Denmark-based medical technology company that develops and markets products and services for people with intimate and chronic healthcare needs. Its primary business areas include ostomy care, continence care, wound and skin care, and interventional urology.
The company’s products include ostomy bags and accessories, catheters for intermittent catheterization, continence care products, wound dressings, and devices used in urological procedures. Coloplast serves patients, healthcare professionals, hospitals, and care providers through direct sales, distributors, and healthcare systems.
Coloplast traces its origins to 1957, when nurse Elise Sørensen developed the first adhesive ostomy bag with assistance from engineer Aage Louis-Hansen.
Featured Stories
- Five stocks we like better than Coloplast A/S
- SpaceX and NVIDIA Want to Put AI Data Centers in Orbit
- These 3 Stocks Sit at the Center of NVIDIA’s Cybersecurity Push
- Lennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. Housing
- Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
